Profile image
Conjoint Professor

Dr Ingrid Van Beek

MBBS, MBA, FAFPHM, FAChAM, MD

Viral Hepatitis Clinical Research Program
E-mail
ingrid.vanbeek@health.nsw.gov.au
Dietze P; Jauncey M; Salmon A; Mohebbi M; Latimer J; Van Beek I; McGrath C; Kerr D, 2019, 'Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial', JAMA Network Open, 2, http://dx.doi.org/10.1001/jamanetworkopen.2019.14977
2019
Dwyer R; Olsen A; Fowlie C; Gough C; van Beek I; Jauncey M; Lintzeris N; Oh G; Dicka J; Fry CL; Hayllar J; Lenton S, 2018, 'An overview of take-home naloxone programs in Australia', Drug and Alcohol Review, 37, pp. 440 - 449, http://dx.doi.org/10.1111/dar.12812
2018
Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I, 2018, 'Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program', Drug and Alcohol Review, 37, pp. 464 - 471, http://dx.doi.org/10.1111/dar.12400
2018
Dietze PM; Draper B; Olsen A; Chronister KJ; van Beek I; Lintzeris N; Dwyer R; Nelson M; Lenton S, 2018, 'Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs', Drug and Alcohol Review, 37, pp. 472 - 479, http://dx.doi.org/10.1111/dar.12680
2018
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I, 2017, 'Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting', International Journal of Drug Policy, 47, pp. 209 - 215, http://dx.doi.org/10.1016/j.drugpo.2017.05.032
2017
Kirwan A; Curtis M; van Beek IA; Cantwell K; Dietze PM, 2016, 'Take-home naloxone programs and calls to emergency services', Medical Journal of Australia, 204, pp. 143 - 143.e1, http://dx.doi.org/10.5694/MJA15.00783
2016
van Beek I; Chronister KJ, 2016, 'Needs-based public health service provision ensures equity', International Journal of Drug Policy, 31, pp. 201 - 202, http://dx.doi.org/10.1016/j.drugpo.2016.02.014
2016
Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L; Day C; Lloyd A; Dore GJ; Walsh N, 2016, 'Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial', Journal of Clinical Virology, 74, pp. 66 - 72, http://dx.doi.org/10.1016/j.jcv.2015.11.031
2016
Ivan M; Rodgers C; Maher L; Van Beek I, 2016, 'Reducing injecting-related injury and diseases in people who inject drugs: Results from a clinician-led brief intervention', Australian Family Physician, 45, pp. 129 - 133
2016
Doyle JS; Grebely J; Spelman T; Alavi M; Matthews GV; Thompson AJ; Dore GJ; Hellard ME; Kaldor J; Marks P; Lloyd A; Haber P; French R; White P; Rawlinson W; Day C; Van Beek I; McCaughan G; Madden A; Dolan K; Farrell G; Crofts N; Sievert W; Baker D, 2016, 'Quality of life and social functioning during treatment of recent hepatitis C infection: A multi-centre prospective cohort', PLoS ONE, 11, pp. e0150655, http://dx.doi.org/10.1371/journal.pone.0150655
2016
van Beek I; Chronister KJ, 2015, 'Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma', International Journal of Drug Policy, 26, pp. 868 - 874, http://dx.doi.org/10.1016/j.drugpo.2015.05.009
2015
Haber PS; Day CA; Topp L; Shanahan M; Wand H; Van Beek I; Maher L, 2015, 'Hepatitis B vaccination for people who inject drugs', The Lancet, 385, pp. 115, http://dx.doi.org/10.1016/s0140-6736(15)60019-8
2015
Ivan M; Van Beek I; Wand H; Maher L, 2015, 'Surveillance of injecting-related injury and diseases in people who inject drugs attending a targeted primary health care facility in Sydney's Kings Cross', Australian and New Zealand Journal of Public Health, 39, pp. 182 - 187, http://dx.doi.org/10.1111/1753-6405.12363
2015
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003
2015
Rodgers C; Ivan M; Maher L; Van Beek I, 2014, 'REDUCING INJECTING-RELATED INJURY AND DISEASES IN PEOPLE WHO INJECT DRUGS - RESULTS OF A PILOT CLINICIAN-LED INTERVENTION', DRUG AND ALCOHOL REVIEW, 33, pp. 53 - 53, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Chronister KJ; Kearley J; Jackson A; Ivan M; Leung S; Lintzeris N; Van Beek I, 2014, 'EVALUATION OF A PEER NALOXONE DISTRIBUTION PROJECT IN SYDNEY, AUSTRALIA, 2012-2014', DRUG AND ALCOHOL REVIEW, 33, pp. 21 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Van Beek I; Tayler P; Chronister KJ, 2014, 'PERFORMANCE AND IMAGE ENHANCING DRUGS INJECTORS' ACCESS TO NEEDLE SYRINGE PROGRAMS - A PUBLIC POLICY DILEMMA', DRUG AND ALCOHOL REVIEW, 33, pp. 59 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Topp LJ; Day C; Wand HC; Deacon RM; Van Beek IA; Haber PS; Shanahan MD; Rodgers CJ; Maher L, 2013, 'A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia', Preventive Medicine, Advance online publication, pp. 1 - 7, http://dx.doi.org/10.1016/j.ypmed.2013.04.013
2013
Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x
2012
van Beek I, 2012, 'Maybe not perfect-but surely good enough?', Int J Drug Policy, 23, pp. 108, http://dx.doi.org/10.1016/j.drugpo.2011.09.011
2012
VAN BEEK I, 2012, 'Response to Islam et al.: Opportunistic and continuing health care for injecting drug users from a nurse‐run needle syringe program‐based primary health‐care clinic', Drug and Alcohol Review, 31, pp. 116 - 117, http://dx.doi.org/10.1111/j.1465-3362.2011.00389.x
2012
Islam MM; Topp L; Conigrave KM; van Beek I; Maher L; White A; Rodgers C; Day C, 2012, 'The reliability of sensitive information provided by injecting drug users in a clinical setting: Clinician-administered versus audio computer-assisted self-interviewing (ACASI)', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 24, pp. 1496 - 1503, http://dx.doi.org/10.1080/09540121.2012.663886
2012
Deacon RM; Topp L; Wand HC; Day C; Rodgers C; Haber P; van Beek I; Maher L, 2012, 'Correlates of susceptibility to hepatitis b among people who inject drugs in Sydney, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 89, pp. 769 - 778, http://dx.doi.org/10.1007/s11524-012-9680-z
2012
Jauncey ME; Van Beek IA; Salmon AM; Maher L, 2011, 'Bipartisan support for Australia’s supervised injecting facility: a decade in the making.', Medical Journal of Australia, 195, pp. 264, http://dx.doi.org/10.5694/mja11.10815
2011
Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033
2011
Topp L; Day C; Wand H; Deacon R; Van Beek I; Haber P; Shanahan M; Rodgers C; Maher L, 2011, 'A RANDOMISED CONTROLLED TRIAL OF CONTINGENCY MANAGEMENT TO INCREASE HEPATITIS B VACCINATION UPTAKE AND COMPLETION AMONG PEOPLE WHO INJECT DRUGS IN AUSTRALIA', DRUG AND ALCOHOL REVIEW, 30, pp. 86 - 87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2011
Matthews G; Pham STP; Hellard M; Grebely J; Zhang L; Oon A; Marks P; Van Beek IA; Rawlinson WD; Kaldor JM; Lloyd AR; Dore GJ; White PA, 2011, 'Patterns and characteristics of Hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian Trial in Acute Hepatitis C', Clinical Infectious Diseases, 52, pp. 803 - 811, http://dx.doi.org/10.1093/cid/ciq200
2011
Salmon A; Van Beek I; Amin J; Kaldor JM; Maher L, 2010, 'The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia', Addiction, 105, pp. 676 - 683, http://dx.doi.org/10.1111/j.1360-0443.2009.02837.x
2010
Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019
2010
Shearer J; Shanahan MD; Darke S; Rodgers CJ; Van Beek IA; McKetin R; Mattick RP, 2010, 'A cost-effectiveness analysis of modafinil therapy for psychostimulant dependence', Drug and Alcohol Review, 29, pp. 235 - 242, http://dx.doi.org/10.1111/j.1465-3362.2009.00148.x
2010
Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850
2010
Day C; White B; Dore G; Van Beek I; Rodgers C; Cunningham P; Wodak A; Maher L, 2010, 'Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status', Drug and Alcohol Dependence, 108, pp. 134 - 137, http://dx.doi.org/10.1016/j.drugalcdep.2009.11.013
2010
Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072
2009
Salmon A; Van Beek I; Amin J; Grulich A; Maher L, 2009, 'High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre', Australian and New Zealand Journal of Public Health, 33, pp. 280 - 283, http://dx.doi.org/10.1111/j.1753-6405.2009.00389.x
2009
Van Beek IA, 2009, 'Harm reduction - an ethical imperative', Addiction, 104, pp. 342 - 343, http://dx.doi.org/10.1111/j.1360-0443.2008.02418.x
2009
Salmon A; Dwyer R; Jauncey M; Van Beek I; Topp L; Maher L, 2009, 'Injecting-related injury and disease among clients of a supervised injecting facility', Drug and Alcohol Dependence, 101, pp. 132 - 136, http://dx.doi.org/10.1016/j.drugalcdep.2008.12.002
2009
Shearer J; Darke S; Rodgers CJ; Slade T; Van Beek IA; Lewis J; Brady D; McKetin R; Mattick RP; Wodak AD, 2009, 'A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence', Addiction, 104, pp. 224 - 233, http://dx.doi.org/10.1111/j.1360-0443.2008.02437.x
2009
Degenhardt LJ; Roxburgh AD; Van Beek IA; Hall WD; Robinson M; Ross JE; Mant A, 2008, 'The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia', Drug and Alcohol Review, 27, pp. 145 - 151, http://dx.doi.org/10.1080/09595230701829413
2008
Kimber J; Hickman M; Degenhardt LJ; Coulson T; Van Beek IA, 2008, 'Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods', Addiction, 103, pp. 1604 - 1613
2008
Kimber J; Mattick RP; Kaldor JM; Van Beek IA; Gilmour S; Rance J, 2008, 'Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre', Drug and Alcohol Review, 27, pp. 602 - 612
2008
White B; Day C; Thein H; Doab A; Bates A; Holden J; Van Beek I; Maher L, 2008, 'Acceptability of hepatitis C virus testing methods among injecting drug users', Drug and Alcohol Review, 27, pp. 666 - 670, http://dx.doi.org/10.1080/09595230801956116
2008
Treloar C; Laybutt B; Jauncey ME; Van Beek IA; Lodge M; Malpas G; Carruthers S, 2008, 'Broadening discussions of `safe` in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice', International Journal of Drug Policy, 19, pp. 59 - 65, http://dx.doi.org/10.1016/j.drugpo.2007.01.005
2008
Micallef JM; Macdonald V; Jauncey ME; Amin J; Rawlinson WD; Van Beek IA; Kaldor JM; White PA; Dore GJ, 2007, 'High Incidence of hepatitis C virus reinfection within a cohort of injecting drug users', Journal of Viral Hepatitis, 14, pp. 413 - 418
2007
Dore GJ; Hellard M; Matthews G; Haber PS; Shaw D; Yeung B; Petoumenos K; Van Beek IA; Mccaughan GW; Pan Y; Ffrench R; Rowlinson W; Lloyd AR; Kaldor JM, 2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A
2007
Macdonald V; Dore GJ; Amin J; Van Beek IA, 2007, 'Predictors of completion of a hepatitis Bvaccination schedule in attendees at a primary health care centre.', Sexual Health, 4, pp. 27 - 30
2007
Amin J; Law MG; Micallef JM; Jauncey ME; Van Beek IA; Kaldor JM; Dore GJ, 2007, 'Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users', Epidemiology and Infection, 135, pp. 144 - 150
2007
van Beek I, 2007, 'Case study: accessible primary health care--a foundation to improve health outcomes for people who inject drugs.', Int J Drug Policy, 18, pp. 329 - 332, http://dx.doi.org/10.1016/j.drugpo.2006.11.005
2007
Fox J; Tideman RL; Gilmour S; Marks C; van Beek I; Mindel A, 2006, 'Sex work practices and condom use in female sex workers in Sydney.', Int J STD AIDS, 17, pp. 319 - 323, http://dx.doi.org/10.1258/095646206776790240
2006
Abelson J; Treloar C; Crawford J; Kippax SC; Van Beek IA; Howard J, 2006, 'Some characteristics of early onset injecting drug users prior to and at the time of their first injection', Addiction, 101, pp. 548 - 555
2006
Jauncey ME; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson WD; Kaldor JM; Van Beek IA; Dore GJ, 2004, 'Clearance of hepatitis C virus after newly acquired infection ininjection drug users', Journal of Infectious Diseases, 190, pp. 1270 - 1274
2004
Freeman A; Ffrench R; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Van Beek IA; Rawlinson WD; Lloyd AR, 2004, 'Prevalence of Production of Virus-Specific Interferon- among Seronegative Hepatitis C-Resistant Subjects Reporting Injection Drug Use', Journal of Infectious Diseases, 190, pp. 1093 - 1097
2004
van Beek I; Kimber J; Dakin A; Gilmour S, 2004, 'The Sydney Medically Supervised Injecting Centre: Reducing harm associated with heroin overdose', Critical Public Health, 14, pp. 391 - 406, http://dx.doi.org/10.1080/09581590400027528
2004
Freeman AJ; Ffrench RA; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Rawlinson WD; Van Beek IA; Lloyd AR, 2004, 'Virus-specific cellular immunity is prevalent among hepatitis C-resistant injecting drug users', Journal of Infectious Diseases, 190, pp. 1093 - 1097
2004
Van Beek IA, 2003, 'The Sydney Medically Supervised Injecting Centre: A Clinical Model', Journal of Drug Issues, 33, pp. 625 - 638
2003
Shearer J; Wodak AD; Van Beek IA; Mattick RP; Lewis J, 2003, 'Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence', Addiction, 98, pp. 1137 - 1141
2003
Thein H; Denoe M; Van Beek IA; Dore GJ; MacDonald MA, 2003, 'Injecting behaviour of injecting drug users at needle and syringe programs and pharmacies in Australia', International Journal of Drug Policy, 14, pp. 425 - 430
2003
Kimber J; Dolan K; Van Beek IA; Hedrich D, 2003, 'Drug consumption facilities: an update since 2000', Drug and Alcohol Review, 22, pp. 227 - 233
2003
MICALLEF J; JAUNCEY M; AMIN J; RAWLINSON W; GILMOUR S; VANBEEK I; KALDOR J; WHITE P; DORE G, 2003, '229 Hepatitis C virus reinfection within a cohort of injecting drug users', Hepatology, 38, pp. 266 - 266, http://dx.doi.org/10.1016/s0270-9139(03)80272-0
2003
Kimber J; MacDonald MA; Van Beek IA; Kaldor JM; Weatherburn D; Lapsley HM; Mattick RP, 2003, 'The Sydney Medically Injecting Centre : Client Characteristics and Predictors of Frequent Attendance Druing the First 12 Months of Operation', Journal of Drug Issues, 33, pp. 639 - 648
2003
Tideman RL; Thompson C; Rose B; Gilmour S; Marks C; Van Beek IA; Berry G; O Connor C; Mindel A, 2003, 'Cervical human papillomavirus infections in commercial sex workers - risk factors and behaviours', International Journal of STD and AIDS, 14, pp. 840 - 847
2003
Shearer J; Sherman J; Wodak AD; Van Beek IA, 2002, 'Substitution therapy for amphetamine users', Drug and Alcohol Review, 21, pp. 179 - 185
2002
Shearer J; Wodak AD; Van Beek IA; Mattick RP; Lewis J, 2002, 'Pilot randomized-double-blind-placebo-controlled study of Dexamphetamine for Cocaine Dependence', Drug and Alcohol Dependence, 66, pp. 162 - 162
2002
VAN BEEK I; DWYER R; MALCOLM A, 2001, 'Cocaine injecting: the sharp end of drug‐related harm!', Drug and Alcohol Review, 20, pp. 333 - 342, http://dx.doi.org/10.1080/09595230120079657
2001
Shearer J; Wodak AD; Mattick RP; Van Beek IA; Lewis J; Hall WD; Dolan K, 2001, 'Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence', Addiction, pp. 1289 - 1296
2001
Harcourt C; van Beek I; Heslop J; McMahon M; Donovan B, 2001, 'The health and welfare needs of female and transgender street sex workers in New South Wales', Australian and New Zealand Journal of Public Health, 25, pp. 84 - 89, http://dx.doi.org/10.1111/j.1467-842X.2001.tb00556.x
2001
Freeman A; Zekry A; Whybin R; Harvey CE; Van Beek IA; De Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G; Lloyd AR, 2000, 'Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s', Medical Journal of Australia, 172, pp. 588 - 591
2000
van Beek I; Gilmour S, 2000, 'Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney.', Aust N Z J Public Health, 24, pp. 540 - 542, http://dx.doi.org/10.1111/j.1467-842x.2000.tb00507.x
2000
MacDonald MA; Wodak AD; Dolan K; Van Beek IA; Cunningham PH; Kaldor JM, 2000, 'Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61
2000
Wodak AD; Van Beek IA; Kaldor JM, 2000, 'Hepatitus C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61
2000
Van Beek IA; Dwyer RG; Dore GJ; Luo K; Kaldor JM, 1998, 'Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study', British Medical Journal: International, pp. 433 - 437
1998
Thackway S; Furner V; Mijch AM; Cooper DA; Holland D; Martinez P; Shaw D; Van Beek IA; Wright E; Clezy KR; Kaldor JM, 1998, 'HIV infection in women in the Asia-Pacific region: the Australian experience', Journal of Hiv Therapy, pp. 9 - 12
1998
MacDonald MA; Wodak AD; Ali RL; Crofts N; Cunningham PH; Dolan K; Kelaher M; Loxley W; Van Beek IA; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in need exchange attenders: a natinoal study', Medical Journal of Australia, 166, pp. 237 - 240
1997
Crofts N; Jolley D; Kaldor JM; Van Beek IA; Wodak AD, 1997, 'The epidemiology of hepatitis C virus infection among injecting drug users in Australia', Journal of Epidemiology and Community Health, pp. 692 - 697
1997
MacDonald MA; Wodak AD; Ali RL; Crofts N; Cunningham PH; Dolan K; Kelaher M; Loxley W; Van Beek IA; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in needle exchange attenders- a national study', Medical Journal of Australia, 166, pp. 237 - 240
1997
Thackway S; Furner V; Mijch AM; Cooper DA; Holland D; Martinez P; Shaw D; Van Beek IA; Wright E; Clezy KR; Kaldor JM, 1997, 'Fertility and reproductive choice in women with HIV-1 infection', AIDS, 11, pp. 663 - 667
1997
Crofts N; Jolley D; Kaldor JM; Van Beek IA; Wodak AD, 1997, 'Epidemiology of hepatitis C virus infection among injecting drug users in Australia', Journal of Epidemiology and Community Health, 51, pp. 692 - 697
1997
Wodak AD; Van Beek IA, 1996, 'HIV and injecting drug use', Medical Journal of Australia, 165, pp. 39 - 40
1996
Van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J, 1994, 'Risk factors for hepatitis C virus infection among injecting drug users in Sydney', Sexually Transmitted Infections, 70, pp. 321 - 324, http://dx.doi.org/10.1136/sti.70.5.321
1994
Gilliver R; Scholey K; Van Beek I; Read P, 2015, 'EXPANDING ACCESS TO HEPATITIS CARE AMONG PEOPLE WHO INJECT DRUGS: ONE YEAR OF FIBROSCANS AT THE KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 34, pp. 28 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Chronister KJ; Tayler P; Read P; Van Beek I, 2015, 'EVALUATING A TARGETED APPROACH TO PERFORMANCE AND IMAGE ENHANCING DRUGS INJECTORS' NEEDLE SYRINGE PROGRAM ACCESS AT KIRKETON ROAD CENTRE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 34, pp. 20 - 21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2015
Gilliver R; Scholey K; Chronister K; van Beek I; Read P, 2015, 'TARGETED PRIMARY HEALTH CARE AND SEXUAL HEALTH SERVICES CAN DELIVER THE HEPATITIS C STRATEGY: ONE YEAR OF FIBROSCANS AT THE KIRKETON ROAD CENTRE (KRC)', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A193 - A194, http://dx.doi.org/10.1136/sextrans-2015-052270.501
2015
Grebely J; Alavi M; Haber P; Day C; Matthews GV; van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Spelman T; Kaldor JM; Dore GJ; Hellard M, 2011, 'IMPACT OF TREATMENT ON INJECTING DRUG USE BEHAVIORS DURING RECENT HCV INFECTION: THE ATAHC STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S174 - S174, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60431-5
2011
Hellard M; Matthews G; Petoumenos K; Grebely J; Haber PS; Van Beek IA; Marks P; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Factors associated with uptake of treatment for acute and early chronic hepatitis C virus infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A344 - A344
2008
Hellard M; Grebely J; Matthews G; Haber PS; Petoumenos K; Yeung B; Van Beek IA; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Impact of illicit drug use on response to therapy during treatment for acute and early chronic HCV infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A337 - A338
2008
Hellard M; Haber P; Day C; Marks P; Matthews G; Yeung B; Nguyen O; Dolan K; Van Beek I; Kaldor J; Dore G, 2006, 'Australian trial in acute hepatitis C: baseline behavioural data', in JOURNAL OF CLINICAL VIROLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S140 - S140, presented at 12th International Symposium on Viral Hepatitis and Liver Disease, FRANCE, Paris, 01 July 2006 - 05 July 2006, http://dx.doi.org/10.1016/S1386-6532(06)80434-8
2006
Hellard M; Dore G; Haber P; Marks P; Matthews G; Yeung B; Nguyen O; Pan Y; Ffrench R; McCaughan G; Van Beek I; White P; Dolan K; Rawlinson W; Lloyd A; Kaldor J, 2006, 'Australian trial in acute hepatitis C: preliminary findings', in JOURNAL OF CLINICAL VIROLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S139 - S139, presented at 12th International Symposium on Viral Hepatitis and Liver Disease, FRANCE, Paris, 01 July 2006 - 05 July 2006, http://dx.doi.org/10.1016/S1386-6532(06)80430-0
2006
Freeman AJ; Zekry A; Whybin LR; Harvey CE; van Beek IA; de Kantzow SL; Rawlinson WD; Boughton CR; Robertson PW; Marinos G, 2000, 'Hepatitis C Virus prevalence and genotype among Australian injecting drug users in the 1970s.', in HEPATOLOGY, W B SAUNDERS CO, pp. 279A - 279A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622400468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2000
Van Beek IA, 2009, Responding to contemporary public health dilemmas among vulnerable populations in inner Sydney, University of New South Wales, http://handle.unsw.edu.au/1959.4/44494
2009
Post JJ; Marinos G; Van Beek IA; Burns M, 2008, 'Exposure and acute viral hepatitis', in HIV, viral hepatitis and STIs - a guide for primary care, edn. 3rd edition, ASHM Australasian Society for HIV Medicine, Darlinghurst, pp. 54 - 62
2008
Van Beek IA, 2002, 'Injecting drug users', in World Health Organization (ed.), Scaling up Antiretroviral Therapy in resource-limited settings, edn. 1st, World Health Organisation, Geneva, pp. 76 - 79
2002
Post JJ; Van Beek IA; Burns MG; Marinos G, 2001, 'Exposure and acute viral hepatitis', in Dore G; Grulich A; Kidd M; Hoy J; McCoy R; Mijch A; Strasser S (ed.), Chapter 5: Blood Borne Viruses: A Guide for Primary Care Practitioners, edn. Original, Australasian Society for HIV Medicine Monograph, Sydney, Australia, pp. 37 - 45
2001
Treloar C; Crawford J; Kippax SC; Howard J; Van Beek IA; Copeland J; Weatherall A; Madden A, 2003, Risk for hepatitis C: Transition and initiation to injecting drug use among youth in a range of injecting drug user networks, National Centre in HIV Social Research, Sydney
2003
Shearer J; Wodak AD; Mattick RP; Van Beek IA; Lewis J; Dolan K, 1999, A randomised controlled trial of the feasibility of monitoring controlled prescribing of dexamphetamine, Original, National Drug & Alcohol Research Centre, Randwick, NSW
1999